@ForteBio

ForteBio offers real-time biomolecular interactions analysis in micro-volume samples, characterizing binding affinity, binding kinetics, and concentration.

 USA
sartorius.com/protein-analysis
Joined July 2009
  • Tweets1.6K
  • Following242
  • Followers384
708Media
Discover the new Octet R series systems by Sartorius, a comprehensive solution for screening and characterising molecular interactions such as protein-protein or protein-drug interactions: bit.ly/3A9YYb3 Label free | Stress free #labelfree #cellculture #therapeutics
2
1
Discover the new Octet R series systems, a comprehensive solution for screening and characterising molecular interactions such as protein-protein or protein-drug interactions. drugtargetreview.com/whitepa…
Sartorius Product Hub

ALT Sartorius Product Hub

1
1
#Alphaviruses cause debilitating disease that effects millions. To aid therapeutic design, scientists from @VUMC_Vaccines characterized human anti-alphavirus mAbs from two survivors of Eastern Equine Encephalitis. Register at Cambridge HEALTHTECH: ow.ly/SLkf50EPHQU
2
4
You can meet @SartoriusGlobal at Biologics Europe: Online event on 26-28 April. We are pleased to announce that they are our platinum sponsor and you can meet them in a variety of ways across the two days. Sign up today (it's free) 👉bit.ly/2Z4h4Kk
Sartorius

ALT Sartorius

1
2
3
Unfortunately, Covid-19 isn't going away anytime soon. Work on #diagnostics is still going on, and very much still important. Read more about how we have developed reagents in just 17 days: aptamergroup.com/sars-cov-2-… #SARSCoV2 #COVID19

Rapid Identification And Development Of SARS-CoV-2 Selective Optimers

Discover how Optimer® technology enables the rapid identification and development of SARS-CoV-2 affinity reagents in just 17 days. Download our application note to explore their superior performance...

aptamergroup.com
CNBC
@CNBC15 Jan 2021
"We are going to live with this virus, we think, forever," Moderna CEO Stephane Bancel said during a panel discussion at #JPM2021. cnb.cx/3nMh6Al
2
1
3
Replying to @Tech_Networks
@Tech_Networks is bringing you the latest news on COVID-19 vaccine research and development. We're interacting with industry and academia to learn about the different approaches that are being taken. Here's a curation of such content! technologynetworks.com/bioph…

Stay Up-to-Date With COVID-19 Vaccine Development

Technology Networks is committed to keeping you updated with the latest research in this space. Here, you'll find a curation of our latest COVID-19 vaccine-related content.

technologynetworks.com
2
Antibodies will play a key role in tackling #COVID19, but what are they and how do they work? @ukCPI has put together a video explaining what antibodies are, and how the #AntibodyTaskforce is working to complement the Government's vaccination strategy. #COVID19Antibodies
9
8
A new #SciMagPerspective reviews data on the growing and diverse impact of #SARSCoV2 on the hearts of patients and highlights a “fundamental and large hole” in researchers’ knowledge base regarding what drives this pathogenesis. Read more: fcld.ly/zm83wnz
2
107
14
257
ForteBio retweeted
IMAPAC@imapac22 Oct 2020
We are honoured to have @Cytiva, BeiGene, CPC, @USPharmacopeia , @BCILifeSciences, @ForteBio, BMS, @ILCDover and Young Sciences Inc. on board for Biologics Manufacturing Korea 2020! We look forward to seeing you there. Be there or be square! #BMK2020 #CTWA2020 #biologics #Imapac
1
3
ForteBio retweeted
nature
@Nature20 Oct 2020
"Taken together, the early clinical data for the Pfizer/BioNTech vaccine candidate hold promise, but many questions remain for this and other mRNA vaccines that target SARS-CoV-2." go.nature.com/3jjNNTs
2
8
2
33
Ambr® 15 Cell Culture automated #bioreactor system helps teams to select better clones, screen more media, and optimize processes faster. Watch the animation on our website to discover the new features and applications. ow.ly/LNJT50BXn4W
2
Existing evidence suggests that vaccine-associated immune enhancement of disease may not be a higher concern for #COVID19 vaccine candidates than for other viral vaccines, according to a new discussion on #VaccineSafety in @ScienceTM. fcld.ly/k3t6h8f
1
52
112
Researchers have found that the level of #antibodies in the serum of SARS-CoV-2 patients correlated with disease severity. #COVID19 #coronavirus Read more here: drugtargetreview.com/news/74…
2
Welcome to the final day of Drug Discovery Digital - mailchi.mp/e8abf9d87a5d/drug…
2
2
Lab-Made ‘Miniproteins’ Could Block the Coronavirus from Infecting Cells: Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce bit.ly/2InLTV2
1
9
17
Understanding how the cell defends itself is particularly important for viruses that have the potential to affect global health, such as #Ebola and #SARSCoV2. New research takes a closer look at inhibiting the entry of these viruses. fcld.ly/p28djnh #SciMagPerspective
59
4
158
IgG & IgM #antibodies for the win! Two separate studies demonstrate #SARSCoV2 antibodies persist for months. @GENbio SARS-CoV-2 Antibodies Persist for Months after Infection bit.ly/3lDIj7E
9
2
18
Welcome to Week 2 of Drug Discovery Digital - mailchi.mp/cce981237f4c/drug…
1
3
In this technical article, writers from @SartoriusGlobal describe how to integrate Raman spectroscopy with Ambr bioreactors using a BioPAT Spectro spectroscopy platform, enabling real-time #Raman #spectroscopy measurement of #bioreactor samples: ow.ly/ICFi50BQc3Y
4
2
A team from @HopkinsMedicine has said that inhibiting the factor D #protein could prevent SARS-CoV-2 from turning the immune system against healthy cells. #COVID19 #coronavirus Find out more: drugtargetreview.com/news/74…
1
1
Load more